Clinical Trials Directory

Trials / Terminated

TerminatedNCT03328598

A Community-based Resilience Program of Only-child Loss Parents

Implementation of a Community-based Resilience Promotion Program to Only-child Loss Parents in China

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
144 (actual)
Sponsor
Central South University · Academic / Other
Sex
All
Age
49 Years
Healthy volunteers
Accepted

Summary

This is a community-based participatory research aiming at helping the only-child loss parents to be happier and resilient from bereavement. It is a psycho-behavioral intervention research. There are two intervention programs in this study. One is derived from a foreign psychotherapy, developed by an American psychologist and has been testified the effectiveness in promoting happiness. Another one is developed by the researchers based on the previous cross-sectional survey and interviews with those bereaved parents. The researchers will apply randomized controlled trial to testify and compare those two intervention programs in a Chinese community.

Conditions

Interventions

TypeNameDescription
BEHAVIORALPositive psychology therapy groupThis program is developed from a foreign group program based on positive psychology. The positive psychology therapy lasts 8 weeks, and has a group intervention in each week. The themes of each week are start-up, time gift, positive mind, three good things, a thankful heart, life train, active service, end-up.
BEHAVIORALResilience promotion therapy groupThe other one is developed from research team's previous research results. The resilience promotion therapy lasts 8 weeks, and also has a group intervention in each week. The themes of each week are start-up, mutual help, trust in yourself, thanksgiving feedback, care for yourself, emotional management, end-up.
OTHERControlled routine activityConventional community activities is viewed as an active comparator for controlled group.

Timeline

Start date
2017-12-01
Primary completion
2018-01-24
Completion
2019-01-31
First posted
2017-11-01
Last updated
2023-08-30

Locations

2 sites across 1 country: China

Source: ClinicalTrials.gov record NCT03328598. Inclusion in this directory is not an endorsement.